# A long-acting octreotide analog formed by conjugation with a peptide linker modified with two fatty acids.

> PubMed lists PMID 42712757 in Frontiers in endocrinology as Journal Article, Randomized Controlled Trial, Clinical Trial, with publication-date metadata of 2026-08-25 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42712757-octreotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-09-09
- Source checked: 2026-09-09
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42712757-octreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42712757-octreotide-v1.json
- Content SHA-256: `721ecbbfac795337fe14299f1f40afdd1f1a902c1f068bcf8585af9769c5b5c4`

## Claims and source pins

### Headline

A long-acting octreotide analog formed by conjugation with a peptide linker modified with two fatty acids. ([`pubmed-observation-pmid-42712757-2026-09-09-36f27a718dd5`](#source-pubmed-observation-pmid-42712757-2026-09-09-36f27a718dd5))

### Summary

PubMed lists PMID 42712757 in Frontiers in endocrinology as Journal Article, Randomized Controlled Trial, Clinical Trial, with publication-date metadata of 2026-08-25 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42712757-2026-09-09-36f27a718dd5`](#source-pubmed-observation-pmid-42712757-2026-09-09-36f27a718dd5))

### Paragraph 1

PubMed lists PMID 42712757 in Frontiers in endocrinology as Journal Article, Randomized Controlled Trial, Clinical Trial, with publication-date metadata of 2026-08-25 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42712757-2026-09-09-36f27a718dd5`](#source-pubmed-observation-pmid-42712757-2026-09-09-36f27a718dd5))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42712757-2026-09-09-36f27a718dd5`](#source-pubmed-observation-pmid-42712757-2026-09-09-36f27a718dd5))

## Sources

<a id="source-pubmed-observation-pmid-42712757-2026-09-09-36f27a718dd5"></a>
- **A long-acting octreotide analog formed by conjugation with a peptide linker modified with two fatty acids. · retained source version 1:2026-09-09:current:36f27a718dd53f76368cf564f08cae7a41857334e4c3d6f76a1390a1b9d98c68** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42712757/) (`pubmed-observation-pmid-42712757-2026-09-09-36f27a718dd5`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "A long-acting octreotide analog formed by conjugation with a peptide linker modified with two fatty acids." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42712757-octreotide-v1.json SHA-256: 721ecbbfac795337fe14299f1f40afdd1f1a902c1f068bcf8585af9769c5b5c4.